Condition
Immunoglobulin A Nephropathy (IgAN) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Immunoglobulin A Nephropathy (IgAN) clinical trials that are recruiting, at sites in 28 countries (most in China (3), Japan (3), United States (3)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 28Countries
Newest Immunoglobulin A Nephropathy (IgAN) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How ARGX-121 affects protein in IgA nephropathy | Phase 2 | Valencia, California and 10 other locations | Recruiting | Aug 19, 2026 |
| ADX-038 with or without telitacicept for Chinese adults with IgA nephropathy, C3G, or IC-MPGN | Phase 2 | Shenzhen, Guangdong and 8 other locations | Recruiting | Apr 13, 2026 |
| Zigakibart treatment for IgA nephropathy | Phase 2 | San Francisco, California and 29 other locations | Recruiting | Aug 28, 2025 |
| Effects of Felzartamab on Adults with Immunoglobulin A Nephropathy | Phase 3 | Little Rock, Arkansas and 264 other locations | Recruiting | Apr 20, 2025 |
All recruiting trials (4)
-
How ARGX-121 affects protein in IgA nephropathy
This study tests whether ARGX-121 can change protein in urine and other kidney outcomes in adults with IgA nephropathy.
-
ADX-038 with or without telitacicept for Chinese adults with IgA nephropathy, C3G, or IC-MPGN
This Phase 2 trial will test whether ADX-038, given alone or with telitacicept, is safe and helps Chinese adults with biopsy-confirmed IgA nephropathy, complement 3 glomerulopathy, or immune complex MPGN.
-
Zigakibart treatment for IgA nephropathy
This trial will test whether the drug zigakibart can slow disease progression in people with biopsy-confirmed IgA nephropathy and persistent proteinuria.
-
Effects of Felzartamab on Adults with Immunoglobulin A Nephropathy
This study is testing if felzartamab infusions can help adults with immunoglobulin A nephropathy reduce protein in their urine and improve kidney function.
Related topics
Quick answers
How many Immunoglobulin A Nephropathy (IgAN) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 28 countries. The most sites are in China (3 trials), Japan (3 trials), United States (3 trials), Brazil (2 trials), Czechia (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.